All about health

Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced a meeting of the Psychopharmacologic Drugs Advisory Committee on June 4 to discuss a new drug application for...

More than 12,600 people rallied together this weekend for BMO Walk so Kids Can Talk, in support of Kids Help Phone ? raising $3.7 million and counting for its #FeelOutLoud campaign....

Quest Diagnostics Incorporated , a leader in diagnostic information services, announced that Jim Davis, Chairman, CEO and President, will speak on the company's strategy, performance and the latest market developments and trends during a fireside...

Danaher Corporation announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the at the Bank of America Securities Health Care Conference in Las Vegas, Nevada on Tuesday, May 14, 2024 at 10:40 a.m. PT. The event...

Precision BioSciences, Inc. , an advanced gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for sophisticated gene edits, including gene elimination, insertion, and excision, today...

Bio-Rad Laboratories, Inc. , a global leader in life science research and clinical diagnostics products, today announced financial results for the first quarter ended March 31, 2024. First-quarter 2024 total net sales were $610.8 million, a...

Prominently featured in The Inner Circle, William Martin is acknowledged as a Top Pinnacle Professional for his contributions to the fields of safety, health, and emergency response. Mr. Martin, the esteemed founder and CEO of Think Tank Project...

Encompass Health announces the opening of Encompass Health Rehabilitation Hospital of Kissimmee, a 50-bed inpatient rehabilitation hospital located at 4950 Calypso Cay Way. The hospital serves patients recovering from debilitating illnesses and...

DURECT Corporation , a late-stage biopharmaceutical company pioneering the development of epigenetic therapies to transform the treatment of serious and life-threatening conditions, including acute organ injury and cancer, today announced that the...

As kids around the country prepare for summer break, many parents think there will be a break from the bullying at schools. While it would be great if bullying took a summer break, it's simply not the case as long as cyberbullying exists. Millions of...

As healthcare continues its rapid...

McKesson Corporation has released its fiscal 2024 fourth quarter financial results. Results can be accessed on McKesson's Investor Relations website at investor.mckesson.com/financials/quarterly-results. As previously announced, the company will...

Mirum Pharmaceuticals, Inc. , a biopharmaceutical company focused on the identification, acquisition, development and commercialization of novel therapies for debilitating rare and orphan diseases, today announced that it will present at the Citizens...

Children's Hospital of Philadelphia (CHOP)'s New Jersey Safety and Health Outcomes (NJ-SHO) Center for Integrated Data and the New Jersey Division of Highway Traffic Safety (HTS) are pleased to announce the launch of njsho.chop.edu, a website that...

Guardant Health, Inc. , a leading precision oncology company, today announced the company will participate in the following investor conferences. BofA Securities 2024 Healthcare Conference in Las Vegas Fireside Chat on Wednesday, May 15 at 10:40...

Biote , a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced financial results for the first quarter ended March 31, 2024. First Quarter 2024...

Repare Therapeutics Inc. ("Repare" or the "Company") , a leading clinical-stage precision oncology company, today reported financial results for the first quarter ended March 31, 2024. "This was a quarter of clinical progress as we await key,...

YS Biopharma Co., Ltd. ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and...

Exelixis, Inc. today announced that members of the company's management team will participate in fireside chats at the following investor conferences in May: BofA Securities 2024 Health Care Conference: Exelixis is scheduled to present at 2:20...

Danaher Corporation announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.27 per share of its common stock, payable on July 26, 2024 to holders of record on June 28, 2024. ABOUT DANAHER     Danaher is a...

Cardinal Health announced today that its Board of Directors approved an increase to its quarterly dividend, to $0.5056 per share, out of the Company's capital surplus. The dividend will be payable on July 15, 2024 to shareholders of record at the...

Neurocrine Biosciences, Inc. will present at the BofA Securities 2024 Health Care Conference at 11:20 a.m. Pacific Time (2:20 p.m. Eastern Time) on Tuesday May 14, 2024 in Las Vegas. Kevin Gorman, Chief Executive Officer, Matt Abernethy, Chief...

The American College of Physicians (ACP) announced a new, three-year strategic priority expanding its commitment to, and support of, physicians in their engagement with continuous learning and professional accountability. ACP has long recognized the...

Savara Inc. , a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that its management team will participate in a fireside chat at the Citizens JMP Life Science Conference on May 14, 2024 at 6:00am...

Janux Therapeutics, Inc. (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its proprietary technology to its Tumor Activated T Cell Engager (TRACTr) and Tumor Activated...

AbCellera today announced financial results for the first quarter of 2024. All financial information in this press release is reported in U.S. dollars, unless otherwise indicated. "We continue to execute on advancing our internal pipeline,...

Veracyte, Inc. today announced financial results for the first quarter ended March 31, 2024. "We had a strong start to 2024, driven by robust growth from our market-leading Decipher Prostate and Afirma tests. We executed upon our strategies to...

Pulse Biosciences, Inc. , a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablationtm (nsPFAtm) technology, today announced business updates and financial results for the first quarter ended March 31, 2024. Recent...

Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") , a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value...

Cumberland Pharmaceuticals Inc. , a specialty pharmaceutical company, today announced that its product portfolio of FDA-approved brands delivered combined revenues of $8.5 million during the first quarter of 2024. The company ended the quarter with...